COST-EFFECTIVENESS ANALYSIS OF STRATEGIES OF AUTOLOGOUS STEM-CELL TRANSPLANTATION AND MAINTENANCE THERAPY FOR TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA IN CHINA

被引：0
|
作者：
Wu, W. [1 ]
Lou, Y. [1 ]
Fan, X. [1 ]
Ding, S. [1 ]
Zhou, Y. [1 ]
Keramat, S. A. [2 ]
Yang, W. [1 ]
Tang, F. [1 ]
Comans, T. [2 ]
Dong, H. [1 ]
机构：
[1] Zhejiang Univ, Hangzhou, Peoples R China
[2] Univ Queensland, Brisbane, Qld, Australia
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE732
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [1] Autologous stem-cell transplantation and maintenance therapy for transplant-eligible multiple myeloma patients: cost-effectiveness analysis based on a network meta-analysis
    Wu, Weijia
    Wang, Yannan
    Lou, Yingting
    Fan, Xiaoyuan
    Yang, Wenqianzi
    Tang, Fengyuan
    Zhao, Zixuan
    Dong, Hengjin
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025,
  • [2] Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia
    Qerimi, Vjollca
    Nestorovska, Aleksandra Kapedanovska
    Sterjev, Zoran
    Genadieva-Stavric, Sonja
    Suturkova, Ljubica
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 327 - 338
  • [3] Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers
    Mohty, Mohamad
    Harousseau, Jean-Luc
    HAEMATOLOGICA, 2014, 99 (03) : 408 - 416
  • [4] Safety and Cost-Effectiveness of Outpatient Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
    Holbro, Andreas
    Ahmad, Imran
    Cohen, Sandra
    Roy, Jean
    Lachance, Silvy
    Chagnon, Miguel
    LeBlanc, Richard
    Bernard, Lea
    Busque, Lambert
    Roy, Denis Claude
    Sauvageau, Guy
    Kiss, Thomas L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (04) : 547 - 551
  • [5] Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myeloma
    Pandya, Chintan
    Hashmi, Shahrukh
    Khera, Nandita
    Gertz, Morie A.
    Dispenzieri, Angela
    Hogan, William
    Siddiqui, Mustaqeem
    Noyes, Katia
    Kumar, Shaji K.
    CLINICAL TRANSPLANTATION, 2014, 28 (10) : 1084 - 1091
  • [6] Autologous Stem-Cell Transplantation for Multiple Myeloma
    Louw, Vernon J.
    Louw, Hymne
    Webb, Michael J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (11): : 1118 - 1119
  • [7] Strategies for induction, autologous hematopoietic stem cell transplantation, consolidation, and maintenance for transplantation-eligible multiple myeloma patients
    McCarthy, Philip L.
    Hahn, Theresa
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 496 - 503
  • [8] Cost-Effectiveness of Novel Agent Regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients in India
    Dixit, Jyoti
    Malhotra, Pankaj
    Mehra, Nikita
    Mathew, Anisha
    Kumar, Lalit
    Singh, Ashish
    Gupta, Nidhi
    Krishnamurthy, Manjunath Nookala
    Roy, Partha Sarathi
    Kataki, Amal Chandra
    Gupta, Sudeep
    Prinja, Shankar
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2024, 22 (04) : 569 - 582
  • [9] The emerging role of consolidation and maintenance therapy for transplant-eligible multiple myeloma patients
    McCarthy, Philip L.
    Einsele, Hermann
    Attal, Michel
    Giralt, Sergio
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (01) : 55 - 66
  • [10] The Determination Trial Impact on Upfront (vs Delayed) Autologous Stem Cell Transplantation for Transplant-Eligible Newly Diagnosed Multiple Myeloma
    Dulka, Brooke
    Bone, Robert N.
    Jeune-Smith, Yolaine
    Baljevic, Muhamed
    Feinberg, Bruce A.
    BLOOD, 2022, 140 : 10958 - 10959
12345